Stay updated with breaking news from Term Liabilities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Minerva Neurosciences, Inc, Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates
Company to Host Conference Call Today at 8:30 a.m. ETBURLINGTON, Mass., March 08, 2023(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central
DALTON, GA / ACCESSWIRE / March 2, 2023 / The Dixie Group, Inc. (NASDAQ:DXYN) today reported financial results for the fiscal year ended December 31, 2022.Net sales for the fiscal year of 2022 were $304
This amount excludes $12,139 thousand of unamortized debt discount as of December 31, 2022. See Note 9-Notes Payable for details. - The amount excludes $437 thousand of unamortized debt discount as... | March 1, 2023
Finished 2022 ahead of guidance, with total revenue of $355.0 million in the fourth quarter, up 6% y/y; total revenue was $361.4 million and up 8% y/y on a...